Influence of cyclosporine on low-density lipoprotein uptake in human lymphocytes

Metabolism: Clinical and Experimental

Volumn 54, Issue 12, 2005, Pages 1620-1625

  Ruiu, Gianluca ^a   Pinach, Silvia ^a   Gambino, Roberto ^a   Uberti, Barbara ^a   Alemanno, Natalina ^a   Pagano, Gianfranco ^a   Cassader, Maurizio ^a,b  

^a UNIVERSITY OF TURIN   (Italy)

^b Dipartimento di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LOW DENSITY LIPOPROTEIN;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; EVALUATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LIPID METABOLISM; LYMPHOCYTE; PRIORITY JOURNAL;

CELLS, CULTURED; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIPOPROTEINS, LDL; LYMPHOCYTES; RECEPTORS, LDL;

EID: 28444461822     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2005.06.010     Document Type: Article

References (33)

1. A.C. Allison Immunosuppressive drugs: the first 50 years and a glance forward Immunopharmacology 47 2000 63 83
2. J.A. Kobashigawa, and B.L. Kasiske Hyperlipidemia in solid organ transplantation Transplantation 63 1997 331 338
3. W.M. Awni, K. Heim-Duthoy, and B.L. Kasiske Impact of lipoproteins on cyclosporine pharmacokinetics and biological activity in transplant patients Transplant Proc 22 1990 1193 1196
4. K.M. Wasan, P.H. Pritchard, M. Ramaswamy, W. Wong, E.M. Donnachie, and L.J. Brunner Differences in lipoprotein lipid concentration and composition modify the plasma distribution of cyclosporine Pharm Res 14 1997 1613 1620
5. M. Lemaire, and J.P. Tillement Role of lipoproteins and erythrocytes in the in vitro binding and distribution of cyclosporin A in the blood J Pharm Pharmacol 34 1982 715 718
6. W.M. Awni, B.L. Kasiske, K. Heim-Duthoy, and K.W. Rao Long-term cyclosporine pharmacokinetic changes in renal transplant recipients: effects of binding and metabolism Clin Pharmacol Ther 45 1989 41 48
7. K.M. Wasan Modification in plasma lipoprotein concentration and lipid composition regulate the biological activity of hydrophobic drugs J Pharmacol Toxicol Methods 36 1996 1 11
8. J. Nemunaitis, H.J. Deeg, and G.C. Yee High cyclosporine levels after bone marrow transplantation associated with hypertriglyceridemia Lancet 2 1986 744 745
9. N. De Klippel, J. Sennesael, J. Lamote, G. Ebinger, and J. De Keyser Cyclosporin leucoencephalopathy induced by intravenous lipid solution Lancet 339 1992 1114 1145
10. J.K. Patel, and J.A. Kobashigawa Cardiac transplant experience with cyclosporine Transplant Proc 36 2 Suppl. 2004 323S 330S
11. P.C. de Groen Cyclosporine, low density lipoprotein, and cholesterol Mayo Clin Proc 63 1988 1012 1021
12. J. Lopez-Miranda, E. Vilella, F. Perez-Jimenez, A. Espino, and J.A. Jimenez-Pereperez Low density lipoprotein metabolism in rats treated with cyclosporine Metabolism 43 1993 678 683
13. O. al Rayyes, A. Wallmark, and C.H. Floren Cyclosporine inhibits catabolism of low density lipoproteins in HepG2 cells by about 25% Hepatology 24 1996 613 619
14. N.D. Vaziri, K. Liang, and H. Azad Effect of cyclosporine on HMG-CoA reductase, cholesterol 7α-hydroxylase, LDL receptor, HDL receptor, and lipoprotein lipase expressions Pharmacology 294 2000 778 783
15. V. Terpstra, E.S. van Amersfoot, A.G. van Velzen, J. Kuiper, and T.J.C. van Berkel Hepatic and extrahepatic scavenger receptors Arterioscler Thromb Vasc Biol 20 2000 1860 1876
16. Z.F. Stephan, and E.C. Yurachek Rapid flow cytometric assay for LDL receptor activity by DiI-labeled LDL J Lipid Res 34 1993 325 330
17. K. Løhne, P. Urdal, T.P. Leren, S. Tonstad, and L. Ose Standardization of a flow cytometric method for measurement of low density lipoprotein receptor activity on blood mononuclear cells Cytometry 20 1995 290 295
18. A. Böyum Isolation of mononuclear cells and granulocytes from human blood Scand J Clin Lab Invest 97 1968 77 89
19. R.J. Havel, H.A. Eder, and J.H. Bragdon The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J Clin Invest 34 1955 1345 1353
20. J.L. Goldstein, and M.S. Brown Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia J Biol Chem 249 1976 5153 5162
21. J.A. Cuthbert, C.A. East, D.W. Bilheimer, and P.E. Lipsky Detection of familial hypercholesterolemia by assaying functional low-density-lipoprotein receptors on lymphocytes N Engl J Med 314 1986 879 883
22. E.E. Powell, and P.A. Kroon Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme-A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver J Clin Invest 93 1994 2168 2174
23. L. Duvillard, P. Gambert, and G. Lizard Etude du recepteur des lipoproteins de basse densite par cytometrie en flux: interest biologiques et cliniques Ann Biol Clin 62 2004 87 91
24. T.L. Innerarity, R.E. Pitas, and R.W. Mahley Lipoprotein-receptor interactions J.J. Albers J.P. Segrest Methods in enzymology vol. 129 1986 Academic Press London 542 565
25. O. al Rayyes, A. Wallmark, and C.H. Floren Reversal of cyclosporine-inhibited low density lipoprotein receptor activity in HepG2 cells by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors Hepatology 25 1997 991 994
26. K.M. Wasan, E.M. Donnachie, D.W. Seccombe, and P.H. Pritchard Effect of cyclosporine on the binding affinity and internalization of low density lipoproteins in human skin fibroblasts J Pharm Sci 91 2002 2520 2524
27. J. Galle, and C. Wanner Modification of lipoproteins in uremia: oxidation, glycation and carbamoylation Miner Electrolyte Metab 25 1999 263 268
28. C. Maczek, H. Recheis, G. Böck, T. Stulnig, G. Jürgens, and G. Wick Comparison of low density lipoprotein uptake by different human lymphocyte subsets: a new method using double-fluorescence staining J Lipid Res 37 1996 1363 1371
29. A. Vathsala, R.B. Weinberg, and L. Schoenberg Lipid abnormalities in renal transplant recipients treated with cyclosporine Transplant Proc 21 1989 3670 3673
30. M. Cassader, G. Ruiu, R. Gambino, N. Alemanno, G. Triolo, and F. Veglia Lipoprotein-apolipoprotein changes in renal transplant recipients Lipids 37 2002 967 974
31. T.M. Stulnig, H. Klocker, and J. Harwood Jr. In vivo LDL receptor and HMG-CoA reductase regulation in human lymphocytes and its alterations during aging Arterioscler Thromb Vasc Biol 15 1995 872 878
32. J.B. De Sanctis, I. Blanca, H. Rivera, and N.E. Bianco Expression of low-density lipoprotein receptors in peripheral blood and tonsil B lymphocytes Clin Exp Immunol 113 1998 206 212
33. M.A. Artz, J.M.M. Boots, and G. Ligtenberg Improved cardiovascular risk profile and renal function in renal transplant patients after randomized conversion from cyclosporine to tacrolimus J Am Soc Nephrol 14 2003 1880 1888